Chronic Stress Associated Indoxyl Sulfate Upregulation Exhausts CD8 + T Cells to Decrease the Efficiency of Anti‐PD‐1 in Hepatocellular Carcinoma
Depressive symptoms are highly prevalent among patients with hepatocellular carcinoma (HCC), yet whether they influence the efficacy of immunotherapy and the underlying mechanisms remain unclear. Integrated analyses of a clinical cohort and murine models demonstrate that chronic stress‐induced depressive‐like states markedly attenuate the antitumor efficacy of anti‐programmed cell death protein 1 (PD‐1) antibodies in HCC, accompanied by enhanced Tcell exhaustion. Mechanistically, chronic stress upregulates hepatic sulfotransferase 1A1 (SULT1A1) expression, thereby promoting the production of the tryptophan metabolite indoxyl sulfate (IS). IS does not directly act on CD8 + T cells but activates the transcription factor aryl hydrocarbon receptor (AHR) in HCC cells, upregulating the E3 ubiquitin ligase ring finger protein 115 (RNF115). RNF115 mediates lysine 27 (K27)‐linked ubiquitination of histone deacetylase 8 (HDAC8) to inhibit its autophagic degradation. Stabilized HDAC8 enhances secretion of the immunosuppressive factor angiopoietin‐like protein 4 (ANGPTL4), thereby contributing to CD8 + Tcell exhaustion and reducing sensitivity to PD‐1 inhibitors. Depletion or inhibition of HDAC8 significantly restores the antitumor efficacy of PD‐1 therapy under chronic stress. Collectively, these findings support a chronic stress‐SULT1A1‐IS‐AHR‐RNF115‐HDAC8 axis that drives immunotherapy resistance in HCC, suggesting a mechanistic link between emotional disturbance and tumor immune microenvironment remodeling.
Authors
- Dongzi Peng (ORCID: https://orcid.org/0000-0002-6707-3728)
- Yu Zhang (ORCID: https://orcid.org/0000-0002-9191-7708)
- Zhuo Xing (ORCID: https://orcid.org/0009-0008-8721-4488)
- Pian Liu (ORCID: https://orcid.org/0000-0001-5780-3902)
- Ruijiang Zeng (ORCID: https://orcid.org/0009-0000-1687-7331)
- Xin Jin (ORCID: https://orcid.org/0000-0001-6461-6005)
- Chong Yang (ORCID: https://orcid.org/0000-0003-4207-4326)
- Zexian Ding
- Mengjun Huang
- Li Gu
- Mengmeng Wang
Institutions
- Ministry of Education of the People's Republic of China (CN)
- Central South University (CN)
- University of Electronic Science and Technology of China (CN)
- Chinese Academy of Sciences (CN)
- Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital (CN)
- Wuhan Union Hospital (CN)
- Second Xiangya Hospital of Central South University (CN)
- Sichuan Academy of Traditional Chinese Medicine (CN)
- Xiangya Hospital Central South University (CN)
- Huazhong University of Science and Technology (CN)
Publication Details
- Journal
- Advanced Science
- Published
- 2026-11-18
- DOI
- https://doi.org/10.1002/advs.78733
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Central South University
- China Postdoctoral Science Foundation
- National Key Research and Development Program of China